Locations:
Search IconSearch

Cole Eye Institute ARVO 2018 Booth Schedule

Visit, listen and learn throughout the conference: booth #1103

18-EYE-1152-ARVO-CQD

From retinopathy of prematurity to AMD to “fishing rods and cones.” Cleveland Clinic Cole Eye Institute researchers and ophthalmologists continue to push the envelope in ophthalmology science, and they are looking forward to sharing some of their fascinating research efforts with you at the 2018 Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Honolulu (April 29-May 3).

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Please join the team at Cole Eye Institute’s booth (#1103) in the Exhibit Hall for these stimulating discussions and talks.

Cleveland Clinic Cole Eye Institute Booth Schedule

SUNDAY, APRIL 29

10-11 a.m., George Hoppe, PhD

11 a.m.-12 p.m., Onkar Sawant, PhD

  • Cole Eye Institute vision science training program

12-1 p.m., Stephanie Hagstrom, PhD

  • Gene polymorphisms and response to anti-VEGF therapy in AMD

MONDAY, APRIL 30

10-11 a.m., Fatema Ghasia, MD

  • Eye movements recordings: A diagnostic and prognostic tool for pediatric eye disorders

12-1 p.m., Charandeep Singh, PhD

  • Metabolomics in retina and eye research

1-2 p.m., Neal Peachey, PhD

  • In vivo electrophysiology of the rodent RPE

TUESDAY, MAY 1

11 a.m.-12 p.m., Vera Bonilha, PhD

  • Oxidative stress and AMD

1-2 p.m., Arun D. Singh, MD

WEDNESDAY, MAY 2

11 a.m.-12 p.m., William J. Dupps Jr., MD, PhD

  • Translational corneal biomechanics: Modeling, measurement and moving to the clinic

12-1 p.m., Sujata Rao, PhD

1-2 p.m., Brian Perkins, PhD

Consult QD is where Cleveland Clinic Cole Eye Institute discusses complex cases and highlights cutting-edge research. Check us out at consultqd.org/oph.

Advertisement

Related Articles

OCT scan showing dry AMD
Autoimmune Disease Linked With Higher Risk of Macular Degeneration

Early data shows risk is 73% higher in patients with lupus, 40% higher in patients with rheumatoid arthritis

Closeup of an eye looking at a needle preparing to inject medication into the eyeball
Measuring the Impact of Ongoing Aflibercept Treatment in Diabetic Retinopathy

Study highlights the value of quantitative ultra-widefield angiography

Eye doctor looking into a man's eye
Faricimab Improves Results for Most Patients on Prior Therapy for nAMD

Switching medications may decrease treatment burden and macular fluid

23-EYE-4215262-CQD-Thyroid-eye-disease-tips-general-ophth-hero
Managing Thyroid Eye Disease: Insights for General Ophthalmologists

Interventions abound for active and stable phases of TED

The Featured Image for the post
November 14, 2023/Ophthalmology/News & Insight
The Art of Ophthalmic Imaging

Cole Eye Institute imaging specialists are equal parts technician, artist and diagnostician

23-EYE-4284060-CQD-Myopia-progression-children
Use Caution When Treating Myopia in Children With Intermittent Exotropia

Effect of low-dose atropine and dual-focus contact lenses is unknown in patients with comorbid eye conditions

Ad